Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02618057` - Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia	Phase 4
Not yet recruiting	`NCT04296383` - Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia	N/A
Not yet recruiting	`NCT06325293` - A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study	N/A
Completed	`NCT02303587` - Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT02618057 - Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

Phase 4

Not yet recruiting

NCT04296383 - Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia

N/A

Not yet recruiting

NCT06325293 - A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study

N/A

Completed

NCT02303587 - Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06348095
Study type	Interventional
Source	Wecare Probiotics Co., Ltd.
Contact
Status	Not yet recruiting
Phase	N/A
Start date	May 27, 2024
Completion date	December 31, 2024

Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms